Horizon successfully completes pilot human gene-editing program
14 June 2011 | By Zyme Communications Ltd
Horizon Discovery has announced that it has successfully completed an eighteen month pilot program with Novartis...
List view / Grid view
News
Abbott receives FDA approval for CREON® (pancrelipase) infant-specific dosage
14 June 2011 | By Abbott
The U.S. FDA approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat EPI due to cystic fibrosis...
GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
14 June 2011 | By GlaxoSmithKline
GSK to acquire the remaining 51% equity interest of Shenzhen Neptunus...
Corning hires biotechnology expert as leader of Corning Life Sciences
13 June 2011 | By Corning Incorporated
Corning Inc., has hired Dr. Richard Eglen, as vice president and general manager of the Corning Life Sciences business segment...
Gilead Sciences’ Kevin Young appointed a Commander of The British Empire
13 June 2011 | By Gilead Sciences, Inc.
Gilead Sciences, Inc. is pleased to announce that Kevin Young, has been appointed a Commander of The British Empire...
Merck and Hanwha Chemical Corporation establish global strategic collaboration
13 June 2011 | By Merck
Merck and Hanwha Chemical Corporation to develop and commercialize a candidate biosimilar form of Enbrel® (etanercept)....
GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)
13 June 2011 | By GlaxoSmithKline
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced that the FDA has approved Potiga™ (ezogabine) Tablets...
Lundbeck announces that Stig Løkke Pedersen, Executive Vice President, Commercial Operations, resigns
10 June 2011 | By H. Lundbeck A/S
H. Lundbeck A/S announced that Stig Løkke Pedersen, EVP for Commercial Operations, has decided to resign from his position at Lundbeck in order to pursue new opportunities...
Novartis candidate vaccine Bexsero® shows potential against meningococcal serogroup B infections
10 June 2011 | By Novartis
New data from a pivotal study in more than 1,800 infants...
Pfizer conducts first “virtual” clinical trial allowing patients to participate regardless of geography
9 June 2011 | By Pfizer Inc.
Pilot study will compare results to previous trial data to assess validity of new approach...
Interim results from Phase III study of treatment for advanced Parkinson’s
9 June 2011 | By Abbott
After 12 weeks of treatment with levodopa-carbidopa intestinal gel patients reported improvement in motor symptoms...
Merck and Intercell terminate Phase II/III clinical trial of V710
8 June 2011 | By Merck
DMC recommends termination of the evaluation of investigational Staphylococcus aureus vaccine, V710...
Thermo Fisher Scientific launches new GC-MS/MS instrument for superior selectivity and sensitivity at ASMS 2011
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new triple quadrupole gas chromatography-mass spectrometry (GC-MS/MS) system designed to offer best-in-class selectivity, analytical performance and productivity.
New research into the production of proteins with extended circulatory half-life
7 June 2011 | By The Scott Partnership
The latest research into the development of proteins...
In shifting regulatory climate Greenphire unveils latest clinical payment solutions at DIA 2011
7 June 2011 | By The Scott Partnership
Greenphire, showcase its ground breaking clinical payment solutions including ClinCard...
